legal-news

Array BioPharma Inc. et al v. Alembic Pharmaceuticals Limited et al

25-cv-01016
Active Hearing stage Sign in to follow this case
Share mail
Advertisement
description

Case Summary

Array BioPharma Inc. and co-plaintiffs filed suit against Alembic Pharmaceuticals Limited and co-defendants in a patent dispute bearing docket 25-cv-01016. The case appears to involve pharmaceutical patent infringement, likely triggered by an Abbreviated New Drug Application (ANDA) filing — a standard mechanism by which generic manufacturers seek approval to market a drug before a brand-name patent expires. The docket reflects active scheduling activity, with at least 48 deadline or hearing entries logged. The case is in active pretrial management. The volume of scheduling entries suggests the parties are working through discovery or claim construction, both of which are typical pressure points in ANDA patent litigation.

Latest development

1:25-cv-01016 Array BioPharma Inc. et al v. Alembic Pharmaceuticals Limited et al

Hearing · April 20, 2026

A scheduling order set deadlines and hearing dates in Array BioPharma Inc. et al v. Alembic Pharmaceuticals Limited et al, Case No. 1:25-cv-01016. The docket entry is sparse — a utility order setting the litigation calendar, likely tied to an initial scheduling conference or case management order.

description View filing

Key Issues

  • • Pharmaceutical patent infringement via ANDA filing
  • • Validity and enforceability of Array BioPharma patents
  • • Generic market entry timing
  • • Claim construction disputes
smart_toy Juryvine case summary generated from primary court records. How we verify our work.

update What Changed This Week

1 event
groups
Hearing 2 hours ago
A scheduling order set deadlines and hearing dates in Array BioPharma Inc. et al v. Alembic Pharmaceuticals Limited et al, Case No. 1:25-cv-01016. The docket entry is sparse — a utility order setting the litigation calendar, likely tied to
receipt_long Source (filing) expand_more

~Util - Set Deadlines/Hearings ( 48

Open original open_in_new

Juryvine summaries are generated from court records. Expand "Source" on any row to see the underlying filing.

Advertisement

Case Timeline

1 event
groups
Hearing April 20, 2026

1:25-cv-01016 Array BioPharma Inc. et al v. Alembic Pharmaceuticals Limited et al

A scheduling order set deadlines and hearing dates in Array BioPharma Inc. et al v. Alembic Pharmaceuticals Limited et al, Case No. 1:25-cv-01016. The docket entry is sparse — a utility order setting the litigation calendar, likely tied to an initial scheduling conference or case management order.

description View filing open_in_new
Advertisement
newspaper

Press Coverage

1 article
settings_backup_restore Data provenance expand_more

Sources tracked

1 outlet · 1 article

Timeline events

1 record on file

Last updated

1 hour, 5 minutes ago

Juryvine aggregates docket entries from PACER/CourtListener, press coverage, and GDELT signals. Ingestion timestamps do not appear in the What Changed feed — that reflects real court activity only.